Pfizer, BioNTech begin testing of third dose against new COVID-19 variants

Washington [US], February 25 (ANI): Pfizer and its partner BioNTech on Thursday said that they have begun to test how well the third dose of their authorised vaccine stacks up against new coronavirus variants.